Archives of the Turkish Society of Cardiology
Complex drug interactions in an HIV-seropositive heart transplant recipient [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2020; 48(2): 180-184 | DOI: 10.5543/tkda.2019.63479

Complex drug interactions in an HIV-seropositive heart transplant recipient

Isabelle Sénéchal1, Nathalie Châteauvert2, Philippe GERVAIS3, Pierre Voisine4, Michelle Dubois5, Mario Sénéchal1
1Department of Cardiology, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Laval University, Québec, Canada
2Department of Pharmacy, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Laval University, Québec, Canada
3Department of Infectious Disease, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Laval University, Québec, Canada
4Department of Cardiac Surgery, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Laval University, Québec, Canada
5Research Center, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Laval University, Québec, Canada

Highly active antiretroviral therapy has led to greater life expectancy for human immun-deficiency virus (HIV)-positive patients. This was a report of 11 years of follow-up of an HIV-seropositive patient who underwent heart transplantation in 2006, with emphasis on the management challenges of complex drug interactions over time.

Keywords: Drug interactions, heart transplantation; human immun-deficiency virus.

How to cite this article
Isabelle Sénéchal, Nathalie Châteauvert, Philippe GERVAIS, Pierre Voisine, Michelle Dubois, Mario Sénéchal. Complex drug interactions in an HIV-seropositive heart transplant recipient. Turk Kardiyol Dern Ars. 2020; 48(2): 180-184

Corresponding Author: Mario Sénéchal, Canada
© Copyright 2020 Archives of the Turkish Society of Cardiology
LookUs & Online Makale